Employers Cut Ozempic, Wegovy Access as Costs Mount

A.M. Edition for Aug. 3. More U.S. employers are cutting off access to popular weight-loss treatments for workers as spending on the drugs leaps into the tens of millions of dollars for insurance plans. Journal pharmaceutical reporter Peter Loftus explains what that means for patients and drugmakers. Plus, a wave of strikes on Ukrainian ports threaten the world’s food supply. And fresh jitters in China’s property market. Luke Vargas hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices